Govt plans to shut down two pharma PSUs

Govt plans to shut down two pharma PSUs

Drug Medicine Pharma manufacturing Factory Industry Unit
Picture: Pixabay

The government has decided to close two pharma public sector undertakings and disinvest the other three, Parliament was informed.

“The Department of Pharmaceuticals has five public sector undertakings (PSUs). Out of the five PSUs, the government has taken a decision to close two pharma PSUs, namely:

Indian Drugs & Pharmaceuticals Ltd (IDPL) and
Rajasthan Drugs & Pharmaceuticals Ltd (RDPL),

said D V Sadananda Gowda, Minister of Chemicals and Fertilisers, in response to a question in the Lok Sabha.

The government has also decided to strategically disinvest the other three:

Hindustan Antibiotics Ltd (HAL),
Bengal Chemicals & Pharmaceuticals Ltd (BCPL), and
Karnataka Antibiotics & Pharmaceutical Ltd (KAPL),

Also read | NPPA caps retail prices of 8 formulations under DPCO-2013

The government has offered voluntary retirement benefits to all employees of IDPL and RDPL, Gowda said.

“However, the Committee of Ministers constituted on September 9, 2019, will take necessary decisions pertaining to closure/strategic sale of the pharma public sector undertakings, including the sale of assets and clearance of outstanding liabilities,” he added.

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Follow and connect with us on Facebook and Linkedin

Go to main website, click here

Subscribe for daily free updates, click here

For daily free updates on WhatsApp, click here

Subscribe here for daily updates